24.61
-0.83 (-3.26%)
| Penutupan Terdahulu | 25.44 |
| Buka | 25.69 |
| Jumlah Dagangan | 2,535,963 |
| Purata Dagangan (3B) | 2,872,878 |
| Modal Pasaran | 4,046,529,792 |
| Harga / Pendapatan (P/E TTM) | 87.89 |
| Harga / Pendapatan (P/E Ke hadapan) | 23.09 |
| Harga / Jualan (P/S) | 1.77 |
| Harga / Buku (P/B) | 1.50 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 30 Apr 2026 |
| Margin Keuntungan | -44.90% |
| Margin Operasi (TTM) | 7.99% |
| EPS Cair (TTM) | -6.54 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -1.10% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -23.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 51.40% |
| Nisbah Semasa (MRQ) | 2.12 |
| Aliran Tunai Operasi (OCF TTM) | 296.50 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 333.84 M |
| Pulangan Atas Aset (ROA TTM) | 1.57% |
| Pulangan Atas Ekuiti (ROE TTM) | -31.33% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Bercampur | Bercampur |
| Medical Instruments & Supplies (Global) | Bercampur | Menurun | |
| Stok | Envista Holdings Corporation | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -4.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -0.5 |
| Purata | -0.50 |
|
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments comprising Specialty Products and Technologies and Equipment and Consumables. The Company’s Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Company’s Equipment & Consumables segment manufactures dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 0.54% |
| % Dimiliki oleh Institusi | 116.92% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Gates Capital Management, Inc. | 31 Dec 2025 | 5,808,119 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 34.00 (Barclays, 38.16%) | Beli |
| Median | 26.00 (5.65%) | |
| Rendah | 25.00 (UBS, 1.59%) | Pegang |
| 25.00 (Piper Sandler, 1.59%) | Pegang | |
| Purata | 27.71 (12.60%) | |
| Jumlah | 2 Beli, 5 Pegang | |
| Harga Purata @ Panggilan | 28.53 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Barclays | 11 Feb 2026 | 34.00 (38.16%) | Beli | 30.26 |
| Mizuho | 10 Feb 2026 | 27.00 (9.71%) | Pegang | 30.17 |
| 20 Jan 2026 | 24.00 (-2.48%) | Pegang | 24.34 | |
| JP Morgan | 06 Feb 2026 | 26.00 (5.65%) | Pegang | 29.10 |
| Piper Sandler | 06 Feb 2026 | 25.00 (1.58%) | Pegang | 29.10 |
| 30 Jan 2026 | 21.00 (-14.67%) | Pegang | 23.47 | |
| Stifel | 06 Feb 2026 | 31.00 (25.97%) | Beli | 29.10 |
| 04 Feb 2026 | 27.00 (9.71%) | Beli | 23.66 | |
| Wells Fargo | 06 Feb 2026 | 26.00 (5.65%) | Pegang | 29.10 |
| UBS | 03 Feb 2026 | 25.00 (1.58%) | Pegang | 22.91 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 05 Feb 2026 | Pengumuman | Envista Reports Fourth Quarter 2025 Results |
| 08 Jan 2026 | Pengumuman | Envista Schedules Fourth Quarter 2025 Earnings Call |
| 07 Jan 2026 | Pengumuman | Envista to Present at the 44th Annual J.P. Morgan Healthcare Conference |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |